Roger M. Perlmutter
Known title: See remarksCIK: 0001184228
Associated companies
Transaction History
| EIKN | ▼ Sell | Other | 284,857 | — | 2/6/2026 | View on chart |
| EIKN | ▼ Sell | Other | 284,857 | — | 2/6/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
EIKN sees institutional buying following NVIDIA and Merck moves
Institutional investors have increased their purchases of Eikon Therapeutics shares, a trend highlighted in a Benzinga article that points to similar buying activity in NVIDIA and Merck. The move suggests growing confidence in EIKN’s prospects. With the stock trading near its 52‑week low and an RSI of 36.6, the new buying activity could be a sign of potential support at the $9.84 level.
EIKN sees institutional buying following NVIDIA and Merck moves. Institutional investors have increased their purchases of Eikon Therapeutics shares, a trend highlighted in a Benzinga article that points to similar buying activity in NVIDIA and Merck. The move suggests growing confidence in EIKN’s prospects. With the stock trading near its 52‑week low and an RSI of 36.6, the new buying activity could be a sign of potential support at the $9.84 level.